Focus:
Biotechnology firm Codagenix has partnered with vaccine manufacturer Serum Institute of India to work together for the development of a vaccine for the new coronavirus.
A study by the US National Institutes of Health (NIH) has demonstrated that Gilead’s antiviral drug, remdesivir, could prevent a type of coronavirus in monkeys.
The University of Pittsburgh, US, has begun efforts to develop a vaccine against the Covid-19 disease caused by the new severe acute respiratory syndrome coronavirus (SARS-CoV-2).
Japan has committed to boosting testing and containment measures for the new coronavirus after confirming its first death, as well as new cases.
Deaths from the new coronavirus, Covid-19 increased to 1,383, including the latest in Japan, as of the end of 13 February. The total number of deaths in mainland China is...
French biotechnology firm OSE Immunotherapeutics has signed a three-year agreement with technology start-up MAbSilico to leverage artificial intelligence (AI) technology for the development of monoclonal antibody drugs.
The Covid-19 death toll has increased to 1,369, indicating 254 new deaths, as of the end of 12 February. Majority of the deaths are in mainland China, along with one...
Dr Reddy’s Laboratories has signed a definitive agreement to acquire certain divisions of Wockhardt’s branded generics business for a consideration of $259.4m (INR18.5bn).
Merck has announced Keytruda (pembrolizumab) combined with chemotherapy met one of two primary endpoints, progression-free survival (PFS), in the Phase III KEYNOTE-355 study of triple negative breast cancer (TNBC) patients.
US-based immunology company Vir Biotechnology has identified two monoclonal antibodies (mAbs) that can bind to the new coronavirus, 2019-nCoV or SARS-CoV-2.
Go Top
